BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

993 related articles for article (PubMed ID: 30470363)

  • 1. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
    Pope NH; Salmon M; Davis JP; Chatterjee A; Su G; Conte MS; Ailawadi G; Upchurch GR
    FASEB J; 2016 Dec; 30(12):4192-4201. PubMed ID: 27619672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Role of IL (Interleukin)-1β in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms.
    Meher AK; Spinosa M; Davis JP; Pope N; Laubach VE; Su G; Serbulea V; Leitinger N; Ailawadi G; Upchurch GR
    Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):843-853. PubMed ID: 29472233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel chronic advanced stage abdominal aortic aneurysm murine model.
    Lu G; Su G; Davis JP; Schaheen B; Downs E; Roy RJ; Ailawadi G; Upchurch GR
    J Vasc Surg; 2017 Jul; 66(1):232-242.e4. PubMed ID: 28274752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor Xa inhibitor rivaroxaban suppresses experimental abdominal aortic aneurysm progression via attenuating aortic inflammation.
    Ding Y; Li X; Zhou M; Cai L; Tang H; Xie T; Shi Z; Fu W
    Vascul Pharmacol; 2021 Feb; 136():106818. PubMed ID: 33227452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.
    Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D Receptor Activation Reduces Angiotensin-II-Induced Dissecting Abdominal Aortic Aneurysm in Apolipoprotein E-Knockout Mice.
    Martorell S; Hueso L; Gonzalez-Navarro H; Collado A; Sanz MJ; Piqueras L
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1587-97. PubMed ID: 27283745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
    Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
    Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Modified Murine Abdominal Aortic Aneurysm Rupture Model Using Elastase Perfusion and Angiotensin II Infusion.
    Yue J; Yin L; Shen J; Liu Z
    Ann Vasc Surg; 2020 Aug; 67():474-481. PubMed ID: 32171859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.
    Tsai SH; Huang PH; Peng YJ; Chang WC; Tsai HY; Leu HB; Chen JW; Lin SJ
    Cardiovasc Res; 2013 Dec; 100(3):501-10. PubMed ID: 24225494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the Th17/IL-17A-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm.
    Wei Z; Wang Y; Zhang K; Liao Y; Ye P; Wu J; Wang Y; Li F; Yao Y; Zhou Y; Liu J
    Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2429-38. PubMed ID: 25234817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of myeloperoxidase in abdominal aortic aneurysm formation: mitigation by taurine.
    Kim HW; Blomkalns AL; Ogbi M; Thomas M; Gavrila D; Neltner BS; Cassis LA; Thompson RW; Weiss RM; Lindower PD; Blanco VM; McCormick ML; Daugherty A; Fu X; Hazen SL; Stansfield BK; Huo Y; Fulton DJ; Chatterjee T; Weintraub NL
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1168-H1179. PubMed ID: 28971841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.
    Kaneko H; Anzai T; Morisawa M; Kohno T; Nagai T; Anzai A; Takahashi T; Shimoda M; Sasaki A; Maekawa Y; Yoshimura K; Aoki H; Tsubota K; Yoshikawa T; Okada Y; Ogawa S; Fukuda K
    Atherosclerosis; 2011 Aug; 217(2):350-7. PubMed ID: 21530968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of a Selective P2Y
    Du X; Zhang S; Xiang Q; Chen J; Tian F; Xu J; Li X; Tan Y; Liu L
    Biomed Res Int; 2020; 2020():1983940. PubMed ID: 32382533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DOCK2 Deficiency Attenuates Abdominal Aortic Aneurysm Formation-Brief Report.
    Guo X; Cai D; Dong K; Li C; Xu Z; Chen SY
    Arterioscler Thromb Vasc Biol; 2023 Jun; 43(6):e210-e217. PubMed ID: 37021575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid prevents angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice.
    Zhai M; Guo J; Ma H; Shi W; Jou D; Yan D; Liu T; Tao J; Duan J; Wang Y; Li S; Lv J; Li C; Lin J; Zhang C; Lin L
    Atherosclerosis; 2018 Apr; 271():128-135. PubMed ID: 29499360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms.
    Filiberto AC; Ladd Z; Leroy V; Su G; Elder CT; Pruitt EY; Hensley SE; Lu G; Hartman JB; Zarrinpar A; Sharma AK; Upchurch GR
    FASEB J; 2022 Nov; 36(11):e22579. PubMed ID: 36183323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.
    Johnston WF; Salmon M; Su G; Lu G; Stone ML; Zhao Y; Owens GK; Upchurch GR; Ailawadi G
    Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):294-304. PubMed ID: 23288154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H; Xu B; Wang W; Tanaka H; Fujimura N; Miyata M; Michie SA; Dalman RL
    J Vasc Surg; 2018 Feb; 67(2):573-584.e2. PubMed ID: 28434702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation.
    Davis JP; Salmon M; Pope NH; Lu G; Su G; Meher A; Ailawadi G; Upchurch GR
    J Vasc Surg; 2016 Jun; 63(6):1602-1612.e2. PubMed ID: 26817611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.